Exelixis EXEL
NASDAQ EXEL
$64.39 +1.71 (+2.73%)
At close: Oct 20, 2026 · 4:00 PM EDT

Exelixis (EXEL) Divestments (2010)

Updated

Exelixis' Divestments came in at $95,000 for Q1 2015.

Analysis

Exelixis (EXEL) Divestments (2010) Analysis & Trends

For FY2014, Exelixis' Divestments was $838,000.

  • Divestments carries a five-year compound annual growth rate of -17.6% (FY2009 to FY2014).
  • Going back by year, Divestments was $3.01 million in FY2011 (-66.6%) and $9 million in FY2010 (+309.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 62.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Exelixis 16.12 Bn 12.46 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 400,000.00
API Access

Exelixis Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=EXEL&period=max&api_key=YOUR_API_KEY